ISRAEL BIOTECH FUND
Israel Biotech Fund โ Building the future of Israeli Biotech Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Based in Rehovot, Israelโs main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages. Our partners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals. Our key... asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fundโs managing partners, provide our portfolio companies with hands-on guidance and support. We donโt just invest in promising companies โ we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance. We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investorโs long-term capital appreciation, while strengthening Israelโs Biotech industry which increases investment opportunities. The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.
ISRAEL BIOTECH FUND
Social Links:
Industry:
Biotechnology Financial Services Medical
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Gravatar Profiles Unified Layer Microsoft DNS JustHost
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
ExpreS2ion
ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.
Neo Kuma Ventures
Psychedelic Healthcare Investment Fund
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-11-01 | Vensica Medical | Israel Biotech Fund investment in Venture Round - Vensica Medical | 16 M USD |
2021-05-13 | Splisense | Israel Biotech Fund investment in Series B - Splisense | 28.5 M USD |
2020-12-02 | BioSight | Israel Biotech Fund investment in Series C - BioSight | 27 M USD |
2020-03-11 | BioSight | Israel Biotech Fund investment in Series C - BioSight | 19 M USD |
2019-05-28 | Ayala Pharmaceuticals | Israel Biotech Fund investment in Series B - Ayala Pharmaceuticals | 30 M USD |
2019-01-08 | Biond Biologics | Israel Biotech Fund investment in Series B - Biond Biologics | 17 M USD |
2018-04-10 | Ayala Pharmaceuticals | Israel Biotech Fund investment in Series A - Ayala Pharmaceuticals | 17 M USD |
2017-06-19 | Gamida Cell | Israel Biotech Fund investment in Series F - Gamida Cell | 40 M USD |
2017-02-27 | Pharma Two B | Israel Biotech Fund investment in Series C - Pharma Two B | 30 M USD |
2016-06-29 | Vidac Pharma | Israel Biotech Fund investment in Series A - Vidac Pharma | 9 M USD |